High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.

Anemia occurs frequently in patients with cancer, with estimates reaching as high as 90% in those with solid tumors. The red blood cell disorder, which may develop because of tumor-related features or ...

Edward’s family knew in their gut that there was something off. After months of chemotherapy and the fight against his stage 3 throat cancer, the doctors had suggested he try a new biologic. This had ...

Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron ...

BOSTON, Feb 22 (Reuters) - Amgen Inc. said on Thursday its anemia drug Aranesp has been removed from a list used by insurance companies to determine whether a drug should be reimbursed for a condition ...

Cancer specialists have long known that anemia, caused by a lack of healthy red blood cells, often arises when cancer metastasizes to the bone, but it's been unclear why. Now, a research team led by ...

Bristol Myers Squibb & Co. (NYSE:BMY) on Friday announced topline results from the Phase 3 INDEPENDENCE trial evaluating Reblozyl (luspatercept-aamt) with concomitant janus kinase inhibitor (JAKi) ...

WASHINGTON — Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely-used anemia drugs that can increase the risk of death and other serious problems ...

(Reuters) - British drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia treatments met their goals in three separate late stage trials. The positive results provide a shot in the arm ...